A total of 100 osteoarthritis patients undergoing unilateral total knee arthroplasty were randomly assigned to receive either a multimodal analgesia protocol, comprising oral celecoxib and tramadol before and after surgery and intra-articular injection of large doses of morphine, ropivacaine, adrenaline and betamethasone during surgery (trial group), or oral and intra-articular placebo (control group). All patients received patient-controlled analgesia for 48 h after surgery. Morphine consumption up to 48 h after surgery was significantly lower in the trial than in the control group. Compared with the control group, the trial group had significantly lower visual analogue scale (VAS) scores for pain at rest from 6 h to 7 days after surgery and significantly lower VAS scores during activity from 24 h to 7 days after surgery. Active straight leg raise and active 90°k nee flexion were achieved sooner and range of knee movement at postoperative days 1 -15 were significantly greater in the trial group. Postoperative wound healing, infection, blood pressure, heart rate, rash, respiratory depression, urinary retention and deep vein thrombosis were similar in the two groups, but nausea and vomiting were significantly less frequent in the trial group.
Introduction
Although total knee arthroplasty (TKA) is a successful procedure for the treatment of degeneration of the knee joint, 1 perioperative pain control is suboptimal. 2,3 At present, post-TKA analgesia includes continuous epidural infiltration, peripheral nerve block, patient-controlled analgesia (PCA), continuous intra-articular infusion of analgesics and local intra-articular analgesic injection. Continuous epidural infiltration and femoral and/or sciatic nerve block improve postoperative pain control and reduce the consumption of opioids 3 at the expense of other potential problems, such as epidural bleeding (with prophylactic anticoagulation therapy), infection, urinary retention, diminished muscle control and nerve damage. 3 -6 Administration of opioids by PCA is often associated with nausea and vomiting, respiratory depression, drowsiness, pruritus, reduced gut motility and urinary retention.
Continuous intra-articular infusion of analgesics is associated with Efficacy of a Multimodal Analgesia Protocol in Total Knee Arthroplasty: a Randomized, Controlled Trial PL Fu, J Xiao, YL Zhu et al. Efficacy of multimodal analgesia in total knee arthroplasty considerable effusion of the surgical wound and may provide direct access for infectious agents. 7 To reduce the occurrence of sideeffects or complications, the analgesia protocol should preferably be multimodal and should block pain at its origin. It should also maintain maximum muscle control to optimize postoperative mobilization, allow active physical therapy and prevent deep vein thrombosis.
This prospective, double-blind, randomized, placebo-controlled study was performed to assess the clinical efficacy and safety of a multimodal analgesia protocol that included oral administration of celecoxib and tramadol and intra-articular injection of an analgesic cocktail during TKA.
Patients and methods

PATIENTS
In this single-centre randomized trial, conducted in the Department of Orthopaedics, Changzheng Hospital, Shanghai, China, patients who were scheduled for unilateral TKA for osteoarthritis between January 2008 and January 2009 were eligible. The inclusion criteria included age < 80 years and weight 45 -75 kg. Exclusion criteria were previous patellectomy, acute or chronic knee infection, major psychological problems, previous drug dependency, allergies to any of the ingredients of the injection, renal insufficiency, abnormal liver enzyme profiles, a history of stroke or a major neurological deficit, or uncontrolled angina and bifascicular blocks with prolonged QT intervals. The termination rules were predefined as severe infection, any anaesthetic accident, arrhythmia and other potential life-threatening complications.
The study was approved by the Ethics Committee of Changzheng Hospital, Shanghai, China, and all patients gave written informed consent to participation in the study.
STUDY DESIGN
A biostatistician who was blinded to the procedure of this research generated a random number sequence from a simple random number table and cards bearing the random numbers were sealed in envelopes. When a patient was enrolled, he or she was randomly and blindly allocated by a research nurse to one of two groups (trial group or control group), according to whether the number was odd or even. The blinding codes were released after the data analysis stage.
INTERVENTIONS
All patients in the trial group received a cyclo-oxygenase 2 (COX-2) inhibitor (celecoxib, 200 mg twice a day) and tramadol (0.1 mg twice a day) orally for 1 day before surgery and for 1 month after surgery. During the operation, patients in this group received an intra-articular injection of an analgesic cocktail. This contained 5 mg morphine, 150 mg ropivacaine (7.5:1000), 0.5 ml adrenaline (1:1000) and 1 ml betamethasone, which were mixed with sterile normal saline solution to make up a combined volume of 50 ml.
All patients in the control group took oral placebo, with appearance and colour that were the same as those of celecoxib and tramadol, on the same dosing schedule as the active treatment. During surgery, patients in the control group were given an intra-articular injection of normal saline solution of the same volume as the cocktail analgesic injection given to the trial group.
All surgical procedures were performed by the same medical team composed of senior PL Fu, J Xiao, YL Zhu et al. Efficacy of multimodal analgesia in total knee arthroplasty surgeons. According to the patient's height, weight and heart function, 10 -15 mg bupivacaine was administered to produce spinal anaesthesia. The operations were performed with the use of a tourniquet, which was inflated during draping and was released before skin closure. Midvastus arthrotomy was used. For patients in the trial group, the first 10 ml of the analgesic cocktail was injected into the posterior aspect of the capsule just before placement of the TKA implant. Care was taken to avoid excessive infiltration in the area of the common peroneal nerve. The posterior stabilized components were then fixed with cement. The patellar surface was trimmed, the cartilage was removed and the peripatellar synovium was cauterized with an electrotome. Before closure of the incision, the quadriceps tendon, the patella tendon and peripatella tissue were infiltrated by injection of another 10 ml of the analgesic cocktail. The remaining 30 ml of the cocktail was used to infiltrate the synovium, fat pad, articular capsule, retinacular tissues, periosteum and subcuticular tissues, avoiding injecting into the skin around the incision. The surgical incision was pressure-dressed without drainage. In the control group, the same volume of normal saline solution was infiltrated in the same area and in the same way as in the trial group. The surgical time and the prevalence of lateral retinacular release were recorded. The surgeons and patients were blinded to the material injected.
All patients in the trial and control groups received PCA (25 mg/100 ml morphine: a 0.5 mg bolus, a 6-min lock-out and a maximum rate of 5 mg/h) for 48 h after surgery. If pain remained intolerable, 5 -10 mg morphine was injected intramuscularly depending on the severity of pain and general condition of the patient. All patients were encouraged to perform active straight leg raising (SLR) after the anaesthetic stage and a continuous passive motion machine was used twice a day to increase the range of movement (ROM) tolerated at 30-min intervals. An intramuscular injection of morphine was administered if the patient required.
OUTCOME MEASURES AND FOLLOW-UP
An evaluator who did not participate in the study and was familiar with the assessment methods used was responsible for collecting the data. The severity of preoperative pain was assessed using a visual analogue scale (VAS), ranging from 0 mm (no pain) to 100 mm (extreme pain), both at rest and during activity. Postoperative pain was assessed in two ways: pain at rest was assessed by measuring VAS at 2, 4, 6, 10, 24 and 36 h and at 2, 7 and 15 days, and pain during activity was assessed by VAS at 24 and 36 h and at 2, 7 and 15 days.
The consumption of morphine was measured at different time points during the 48-h postoperative period and calculated as the amount given by PCA plus the amount given by intramuscular injection.
The period from surgery to achieving SLR and 90°knee flexion, and ROM at postoperative days 1, 3, 7, 15 and 90 were recorded. Doppler ultrasonography was performed in all patients to confirm the presence or absence of deep vein thrombosis at postoperative day 10. Data on blood pressure, heart rate and adverse reactions, including nausea and vomiting, urinary retention, respiratory depression and rash were also collected.
All patients were followed up 1, 3, 6 and 12 months after operation and at yearly intervals thereafter to see whether there was any delayed infection. 
STATISTICAL ANALYSIS
The mean ± SD for continuous variables and the frequency and percentage for categorical variables were calculated. Analysis was performed using the SPSS ® statistical package, version 11.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . Binary categorical variables were analysed by the χ 2 -test and Fisher's exact test, continuous variables were analysed using the Student's t-test and, if the distribution of the variables was nonnormal, Wilcoxon's rank sum test was adopted. A P-value < 0.05 was considered to be statistically significant.
Results
Of 151 prospective subjects who responded to the research notice, 100 met the criteria for study entry and were randomized to receive the trial intervention or placebo. The two groups were followed up for a mean of 7.5 months (range 6 -9 months).
The two groups did not differ significantly in terms of baseline demographic and clinical data (age, gender, body mass index, ROM and VAS) or surgical time. Lateral retinacular release was conducted in four patients in the trial group and three patients in the control group; the difference was not statistically significant (Table 1) .
Consumption of morphine at 0 -12, 12 -24 and 24 -36 h after operation and total morphine consumption in the trial group were significantly lower than in the control group (P < 0.05 for all comparisons; Fig. 1 ). There was no significant difference in the consumption of morphine at 36 -48 h between the two groups.
The VAS scores for pain at rest was significantly lower at 6, 10, 24 and 36 h, and at 2 and 7 days after operation in the trial group compared with values in the control group (P < 0.05 for all comparisons), but the VAS scores for the two groups did not differ significantly before surgery or at 2 and 4 h and at 15 days after surgery ( Fig. 2A) . The VAS scores during activity were significantly lower in the trial group at 24 and 36 h and at 2 and 7 days after operation compared with the control group (P < 0.05 for all comparisons), but the difference between the two groups was not significant before and 15 days after surgery (Fig. 2B) . Mean ROM at postoperative days 1, 3, 7 and 15 was significantly greater in the trial group than in the control group (P < 0.05 for all comparisons, but the difference between the two groups was not significant at postoperative day 90 (Fig. 2C) . The intervals from the operation until the patient was able 
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to perform SLR and 90°knee flexion were significantly shorter in the trial group than in the control group (P < 0.0001 for both; Table 2 ).
There were no significant differences between the two groups in terms of mean ± SD systolic or diastolic blood pressure or heart rate, or in the incidence of urinary retention, respiratory depression, rash or deep vein thrombosis. Doppler ultrasonography of the lower extremities confirmed the presence of deep vein thrombosis in eight patients in the trial group and nine in the control group (the difference was not statistically significant). A significantly higher incidence of nausea and vomiting was recorded in the control group compared with the trial group (P = 0.0215). Wound healing complications occurred in two patients in the trial group and two in the control group, which soon resolved with repeated changes of dressings. No infection from the incision made for the TKA or from the local intra-articular injection occurred in any patient. No sign of deep infection was observed at the last follow-up (Table 3 ).
Discussion
Good pain relief is important for postoperative knee rehabilitation and may influence the overall outcome. Surgical trauma during TKA modifies the responsiveness of the nervous system in two ways: (i) it causes peripheral sensitization by reducing the threshold for afferent nociceptive neurons, and (ii) it causes central sensitization by increasing the excitability of spinal neurons. 8 Together, these changes contribute to hypersensitivity to postoperative pain, increasing the response to noxious stimuli and decreasing the pain threshold at the site of the injured tissue and the surrounding uninjured tissues. 8 The pre-emptive use of analgesia has been shown to prevent central sensitization and improve postoperative pain control. 9,10 Thus, in the present study, celecoxib and tramadol were used routinely before surgery and an intraoperative injection of opioid analgesics was given to try to provide pre-emptive analgesia.
Intra-articular analgesia has aroused increasing attention and interest. It is generally accepted that morphine exerts its found that injection of a small dose of morphine into the articular cavity of the knee after arthroscopy produced a marked analgesic effect, but naloxone, an opioidspecific antagonist, could reverse this effect, indicating the existence of morphine-specific receptors in the articular cavity. This finding suggested a possible new direction for research into the clinical use of opioids for local intra-articular analgesia. The results of arthroscopic studies and animal studies 11 -13 have shown that peripherally administered opioids can produce powerful analgesia in stress and inflammatory conditions. Local administration allows a sustained effect with a minimum of the typical side-effects of opioids (e.g. sedation, nausea and respiratory depression), which occur through central opioid receptors. Local administration of morphine has been shown to reduce postoperative pain in joint arthroplasty. 12 Postoperative analgesia can be provided by intra-articular administration of bupivacaine, 14 but this effect may last only a few hours.
On the basis of our previous trial, 15 we modified the cocktail analgesic injection by adding ropivacaine rather than bupivacaine; ropivacaine is a long-acting analgesic with efficacy similar to that of bupivacaine but with fewer cardiovascular and neurotoxic side effects. 16 -18 Also, the addition of a large dose of adrenaline (0.5 mg, 1:100 000 in 50 ml) to the local anaesthetics probably slowed the release of the ropivacaine into the vascular system and prolonged its local action (ropivacaine has a half-life of 1.7 h). 19 Unlike other studies, 8,20 betamethasone was included in the analgesic injection in the present study, and this multimodal analgesia protocol helped to relieve postoperative pain, reduced requests for postoperative anaesthetics and promoted early rehabilitation without significant risks after TKA. 
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Numerous studies have demonstrated that corticosteroids have potent local antiinflammatory effects and can reduce local stress responses to surgical trauma. By potently suppressing these physiological responses to surgery, pain and functional recovery are improved. Local injection of corticosteroids has been used extensively in musculoskeletal tissues and joints without causing impairment to wound healing or other complications. 21 -23 Wang et al. 24 found that patients who had been given an intraarticular injection of 10 mg triamcinolone at the end of arthroscopic knee surgery had lower pain scores between 6 and 24 h after the operation than the saline-injected control group. Furthermore, the proportion of patients requesting an analgesic bolus was significantly greater in the control group than in the group of patients who had received corticosteroids. In terms of safety, Parvataneni et al. 20 in a randomized controlled study found that addition of a small dose of methylprednisolone (40 mg) to the intraarticular analgesic injection mixture for local analgesia did not result in any case of prolonged incision healing and deep infection among 35 patients receiving total hip arthroplasty and 31 patients receiving TKA. Thus, in the present study, a small dose of betamethasone was also included in the analgesic cocktail injection. The follow-up showed that prolonged healing occurred in two patients (4%) in each group. The incidence of poor incision healing in the trial group was no higher than that in the control group. Healing occurred in all patients after repeated changes of the dressing. We believe, therefore, that local administration of a small dose of betamethasone in the analgesic injection is safe, but care should be taken to avoid injecting into the skin.
In our previous trial, 15 we found that giving an intra-articular cocktail analgesic injection without also giving celecoxib and tramadol orally after TKA reduced the VAS pain score only at 6, 10, 24 and 36 h at rest and at 24 and 36 h during activity. In contrast, in the present study it was found that giving celecoxib and tramadol orally reduced the VAS pain score postoperatively at 48 h and 7 days both at rest and during activity. From this it was concluded that the morphine and ropivacaine in the cocktail analgesic injection would be metabolized after 48 h but, subsequently, drugs with two different pharmacological mechanisms of action (celecoxib and tramadol) would then be active in providing relief. Tramadol is a centrally acting non-narcotic analgesic that binds to µ-opioid receptors and inhibits the reuptake of 5-hydroxytryptamine and noradrenaline. It is used to treat moderate to moderately severe pain. Celecoxib is a nonsteroidal anti-inflammatory drug that blocks an enzyme involved in the production of prostaglandins (cyclooxygenase 2), resulting in lower concentrations of prostaglandins. As a consequence of taking tramadol and celecoxib, inflammation and its accompanying pain, fever, swelling and tenderness are reduced. Taking celecoxib and tramadol orally together could reduce the dose that would be required for a single drug, thereby potentially reducing their side effects. We considered that both celecoxib and tramadol were indispensable in the multimodal analgesia protocol used in the present study. It is important to note, however, that one limitation in the present study's design was that it was not possible to determine the relative contributions of the various components of the medications to both the efficacy and safety of the regimens.
